Oncology Today with Dr Neil Love

348 Avsnitt

1. Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

   Publicerades: 2024-05-20
2. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

   Publicerades: 2024-05-13
3. Virtual Case Library: Metastatic Triple-Negative Breast Cancer

   Publicerades: 2024-05-08
4. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

   Publicerades: 2024-05-06
5. Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

   Publicerades: 2024-05-03
6. Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

   Publicerades: 2024-05-01
7. Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

   Publicerades: 2024-04-26
8. Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

   Publicerades: 2024-04-24
9. Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

   Publicerades: 2024-04-23
10. Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

    Publicerades: 2024-04-15
11. Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences

    Publicerades: 2024-04-12
12. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

    Publicerades: 2024-04-05
13. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer

    Publicerades: 2024-04-05
14. The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

    Publicerades: 2024-04-03
15. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer

    Publicerades: 2024-03-27
16. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

    Publicerades: 2024-03-26
17. Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

    Publicerades: 2024-03-25
18. Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

    Publicerades: 2024-03-21
19. Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

    Publicerades: 2024-03-19
20. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer

    Publicerades: 2024-03-15